<!DOCTYPE html>
<!--
==============================================================================
           "GitHub HTML5 Pandoc Template" v2.1 — by Tristano Ajmone           
==============================================================================
Copyright © Tristano Ajmone, 2017, MIT License (MIT). Project's home:

- https://github.com/tajmone/pandoc-goodies

The CSS in this template reuses source code taken from the following projects:

- GitHub Markdown CSS: Copyright © Sindre Sorhus, MIT License (MIT):
  https://github.com/sindresorhus/github-markdown-css

- Primer CSS: Copyright © 2016-2017 GitHub Inc., MIT License (MIT):
  http://primercss.io/

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
The MIT License 

Copyright (c) Tristano Ajmone, 2017 (github.com/tajmone/pandoc-goodies)
Copyright (c) Sindre Sorhus <sindresorhus@gmail.com> (sindresorhus.com)
Copyright (c) 2017 GitHub Inc.

"GitHub Pandoc HTML5 Template" is Copyright (c) Tristano Ajmone, 2017, released
under the MIT License (MIT); it contains readaptations of substantial portions
of the following third party softwares:

(1) "GitHub Markdown CSS", Copyright (c) Sindre Sorhus, MIT License (MIT).
(2) "Primer CSS", Copyright (c) 2016 GitHub Inc., MIT License (MIT).

Permission is hereby granted, free of charge, to any person obtaining a copy
of this software and associated documentation files (the "Software"), to deal
in the Software without restriction, including without limitation the rights
to use, copy, modify, merge, publish, distribute, sublicense, and/or sell
copies of the Software, and to permit persons to whom the Software is
furnished to do so, subject to the following conditions:

The above copyright notice and this permission notice shall be included in all
copies or substantial portions of the Software.

THE SOFTWARE IS PROVIDED "AS IS", WITHOUT WARRANTY OF ANY KIND, EXPRESS OR
IMPLIED, INCLUDING BUT NOT LIMITED TO THE WARRANTIES OF MERCHANTABILITY,
FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT. IN NO EVENT SHALL THE
AUTHORS OR COPYRIGHT HOLDERS BE LIABLE FOR ANY CLAIM, DAMAGES OR OTHER
LIABILITY, WHETHER IN AN ACTION OF CONTRACT, TORT OR OTHERWISE, ARISING FROM,
OUT OF OR IN CONNECTION WITH THE SOFTWARE OR THE USE OR OTHER DEALINGS IN THE
SOFTWARE.
==============================================================================-->
<html>
<head>
  <meta charset="utf-8" />
  <meta name="generator" content="pandoc" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes" />
  <title>Intestinal helminths  v3.0 MeG-CLS-009</title>
  <style type="text/css">
@charset "UTF-8";.markdown-body{-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;color:#24292e;font-family:-apple-system,system-ui,BlinkMacSystemFont,"Segoe UI",Helvetica,Arial,sans-serif,"Apple Color Emoji","Segoe UI Emoji","Segoe UI Symbol";font-size:16px;line-height:1.5;word-wrap:break-word;box-sizing:border-box;min-width:200px;max-width:980px;margin:0 auto;padding:45px}.markdown-body a{color:#0366d6;background-color:transparent;text-decoration:none;-webkit-text-decoration-skip:objects}.markdown-body a:active,.markdown-body a:hover{outline-width:0}.markdown-body a:hover{text-decoration:underline}.markdown-body a:not([href]){color:inherit;text-decoration:none}.markdown-body strong{font-weight:600}.markdown-body h1,.markdown-body h2,.markdown-body h3,.markdown-body h4,.markdown-body h5,.markdown-body h6{margin-top:24px;margin-bottom:16px;font-weight:600;line-height:1.25}.markdown-body h1{font-size:2em;margin:.67em 0;padding-bottom:.3em;border-bottom:1px solid #eaecef}.markdown-body h2{padding-bottom:.3em;font-size:1.5em;border-bottom:1px solid #eaecef}.markdown-body h3{font-size:1.25em}.markdown-body h4{font-size:1em}.markdown-body h5{font-size:.875em}.markdown-body h6{font-size:.85em;color:#6a737d}.markdown-body img{border-style:none}.markdown-body svg:not(:root){overflow:hidden}.markdown-body hr{box-sizing:content-box;height:.25em;margin:24px 0;padding:0;overflow:hidden;background-color:#e1e4e8;border:0}.markdown-body hr::before{display:table;content:""}.markdown-body hr::after{display:table;clear:both;content:""}.markdown-body input{margin:0;overflow:visible;font:inherit;font-family:inherit;font-size:inherit;line-height:inherit}.markdown-body [type=checkbox]{box-sizing:border-box;padding:0}.markdown-body *{box-sizing:border-box}.markdown-body blockquote{margin:0}.markdown-body ol,.markdown-body ul{padding-left:2em}.markdown-body ol ol,.markdown-body ul ol{list-style-type:lower-roman}.markdown-body ol ol,.markdown-body ol ul,.markdown-body ul ol,.markdown-body ul ul{margin-top:0;margin-bottom:0}.markdown-body ol ol ol,.markdown-body ol ul ol,.markdown-body ul ol ol,.markdown-body ul ul ol{list-style-type:lower-alpha}.markdown-body li>p{margin-top:16px}.markdown-body li+li{margin-top:.25em}.markdown-body dd{margin-left:0}.markdown-body dl{padding:0}.markdown-body dl dt{padding:0;margin-top:16px;font-size:1em;font-style:italic;font-weight:600}.markdown-body dl dd{padding:0 16px;margin-bottom:16px}.markdown-body code{font-family:SFMono-Regular,Consolas,"Liberation Mono",Menlo,Courier,monospace}.markdown-body pre{font:12px SFMono-Regular,Consolas,"Liberation Mono",Menlo,Courier,monospace;word-wrap:normal}.markdown-body blockquote,.markdown-body dl,.markdown-body ol,.markdown-body p,.markdown-body pre,.markdown-body table,.markdown-body ul{margin-top:0;margin-bottom:16px}.markdown-body blockquote{padding:0 1em;color:#6a737d;border-left:.25em solid #dfe2e5}.markdown-body blockquote>:first-child{margin-top:0}.markdown-body blockquote>:last-child{margin-bottom:0}.markdown-body table{display:block;width:100%;overflow:auto;border-spacing:0;border-collapse:collapse}.markdown-body table th{font-weight:600}.markdown-body table td,.markdown-body table th{padding:6px 13px;border:1px solid #dfe2e5}.markdown-body table tr{background-color:#fff;border-top:1px solid #c6cbd1}.markdown-body table tr:nth-child(2n){background-color:#f6f8fa}.markdown-body img{max-width:100%;box-sizing:content-box;background-color:#fff}.markdown-body code{padding:.2em 0;margin:0;font-size:85%;background-color:rgba(27,31,35,.05);border-radius:3px}.markdown-body code::after,.markdown-body code::before{letter-spacing:-.2em;content:" "}.markdown-body pre>code{padding:0;margin:0;font-size:100%;word-break:normal;white-space:pre;background:0 0;border:0}.markdown-body .highlight{margin-bottom:16px}.markdown-body .highlight pre{margin-bottom:0;word-break:normal}.markdown-body .highlight pre,.markdown-body pre{padding:16px;overflow:auto;font-size:85%;line-height:1.45;background-color:#f6f8fa;border-radius:3px}.markdown-body pre code{display:inline;max-width:auto;padding:0;margin:0;overflow:visible;line-height:inherit;word-wrap:normal;background-color:transparent;border:0}.markdown-body pre code::after,.markdown-body pre code::before{content:normal}.markdown-body .full-commit .btn-outline:not(:disabled):hover{color:#005cc5;border-color:#005cc5}.markdown-body kbd{box-shadow:inset 0 -1px 0 #959da5;display:inline-block;padding:3px 5px;font:11px/10px SFMono-Regular,Consolas,"Liberation Mono",Menlo,Courier,monospace;color:#444d56;vertical-align:middle;background-color:#fcfcfc;border:1px solid #c6cbd1;border-bottom-color:#959da5;border-radius:3px;box-shadow:inset 0 -1px 0 #959da5}.markdown-body :checked+.radio-label{position:relative;z-index:1;border-color:#0366d6}.markdown-body .task-list-item{list-style-type:none}.markdown-body .task-list-item+.task-list-item{margin-top:3px}.markdown-body .task-list-item input{margin:0 .2em .25em -1.6em;vertical-align:middle}.markdown-body::before{display:table;content:""}.markdown-body::after{display:table;clear:both;content:""}.markdown-body>:first-child{margin-top:0!important}.markdown-body>:last-child{margin-bottom:0!important}.Alert,.Error,.Note,.Success,.Warning{padding:11px;margin-bottom:24px;border-style:solid;border-width:1px;border-radius:4px}.Alert p,.Error p,.Note p,.Success p,.Warning p{margin-top:0}.Alert p:last-child,.Error p:last-child,.Note p:last-child,.Success p:last-child,.Warning p:last-child{margin-bottom:0}.Alert{color:#246;background-color:#e2eef9;border-color:#bac6d3}.Warning{color:#4c4a42;background-color:#fff9ea;border-color:#dfd8c2}.Error{color:#911;background-color:#fcdede;border-color:#d2b2b2}.Success{color:#22662c;background-color:#e2f9e5;border-color:#bad3be}.Note{color:#2f363d;background-color:#f6f8fa;border-color:#d5d8da}.Alert h1,.Alert h2,.Alert h3,.Alert h4,.Alert h5,.Alert h6{color:#246;margin-bottom:0}.Warning h1,.Warning h2,.Warning h3,.Warning h4,.Warning h5,.Warning h6{color:#4c4a42;margin-bottom:0}.Error h1,.Error h2,.Error h3,.Error h4,.Error h5,.Error h6{color:#911;margin-bottom:0}.Success h1,.Success h2,.Success h3,.Success h4,.Success h5,.Success h6{color:#22662c;margin-bottom:0}.Note h1,.Note h2,.Note h3,.Note h4,.Note h5,.Note h6{color:#2f363d;margin-bottom:0}.Alert h1:first-child,.Alert h2:first-child,.Alert h3:first-child,.Alert h4:first-child,.Alert h5:first-child,.Alert h6:first-child,.Error h1:first-child,.Error h2:first-child,.Error h3:first-child,.Error h4:first-child,.Error h5:first-child,.Error h6:first-child,.Note h1:first-child,.Note h2:first-child,.Note h3:first-child,.Note h4:first-child,.Note h5:first-child,.Note h6:first-child,.Success h1:first-child,.Success h2:first-child,.Success h3:first-child,.Success h4:first-child,.Success h5:first-child,.Success h6:first-child,.Warning h1:first-child,.Warning h2:first-child,.Warning h3:first-child,.Warning h4:first-child,.Warning h5:first-child,.Warning h6:first-child{margin-top:0}h1.title,p.subtitle{text-align:center}h1.title.followed-by-subtitle{margin-bottom:0}p.subtitle{font-size:1.5em;font-weight:600;line-height:1.25;margin-top:0;margin-bottom:16px;padding-bottom:.3em}div.line-block{white-space:pre-line}
  </style>
  <style type="text/css">code{white-space: pre;}</style>
  <!--[if lt IE 9]>
    <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.7.3/html5shiv-printshiv.min.js"></script>
  <![endif]-->
<script src="myScript.js"></script><link rel="stylesheet" href="myStyle.css"></head>
<body> <div w3-include-html="panel.html"></div> <script> includeHTML(); </script>
<article class="markdown-body">
<h1 id="intestinal-helminth-infection">Intestinal helminth infection</h1>
<h2 id="executive-summary"><em>Executive summary</em></h2>
<h2 id="introduction">Introduction</h2>
<p>Helminths are small worms and parasites that often cause illness when they infect human beings. The commonest helminth infections are those affecting the intestines including ascariasis, trichuriasis and hookworms.</p>
<h2 id="target-user">Target User</h2>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Doctors</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Nurses</p>
</div></li>
</ul>
<h2 id="target-area-of-use">Target area of use </h2>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Gate clinic</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Outpatient Department</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Ward</p>
</div></li>
</ul>
<h2 id="key-areas-of-focusnew-additionschanges">Key areas of focus/new additions/changes</h2>
<p>A vast majority of intestinal helminths infections are asymptomatic, however infected persons may present with pulmonary or potentially severe gastrointestinal complaints.</p>
<p>The guidelines do not address the management of complications of intestinal helminth infections such as biliary colic, cholangitis, liver abscess, pancreatitis, intestinal obstruction or appendicitis.</p>
<h2 id="limitations">Limitations </h2>
<p>Increase in IgE and later IgG markers may well be suggestive of an Intestinal helminth infection and PCR is another diagnostic tool for helminths, however, these tests are not readily available in our setting.</p>
<h2 id="presenting-symptoms-and-signs">Presenting symptoms and signs</h2>
<p>Patients often complain that they have worms or blame their symptoms on a worm – even symptoms that are not usually associated with worms. In fact, most worm infections (of all kinds) are asymptomatic.</p>
<p>Intestinal worms may present with</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>itching around the anus,</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>abdominal pain or bloating,</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>nausea and vomiting,</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>passage of worms in the stools,</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>melaena,</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>cough and wheezing (a consequence of larval migration through the lungs),</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>flatulence,</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>failure to thrive</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>microscopic blood loss in the stools and</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>iron deficiency anaemia.</p>
</div></li>
</ul>
<p>More rarely, ascariasis can cause biliary colic, cholangitis, liver abscess, pancreatitis, intestinal obstruction or appendicitis. The adult worms may be coughed up from the lungs. Trichuriasis can cause rectal prolapse in young children.</p>
<p>Hookworms can invade the skin and cause “creeping eruption” – a snake-like itchy red rash which moves through the skin.</p>
<h3 id="classificationcauses">Classification/Causes</h3>
<p>Below is a list of common intestinal helminths that cause diseases:</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p><em>Ascaris lumbricoides</em> (Roundworm)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p><em>Trichuris trichuria</em> (whip worm)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p><em>Enterobius vermicularis</em> (pin worm or thread worm)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p><em>Necator americanus</em> (hookworm)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p><em>Strongyloides stercoralis.</em></p>
</div></li>
</ul>
<h2 id="examination-findings">Examination findings</h2>
<p>Skin and pulmonary findings are minimal. Physical findings in the early stage of the disease may present as erythematous, pruritic, papulovesicular rash at the site of initial infection as in the case of hookworm infestation.</p>
<p>When the worm breaks through from the venous circulation into the pulmonary air spaces, cough, fever and reactive bronchoconstriction may be observed (eg hookworm, strongyloidiasis)</p>
<p>Vague gastrointestinal signs such as mild abdominal tenderness may be present.</p>
<p>Neurologic manifestations such as altered mental state, focal seizures and nuchal rigidity may be seen in severe strongyloidiasis.</p>
<p>Later signs of helminth infection include signs of anaemia (pallor, spooning nails, tachycardia, signs of high output cardiac failure). Hypoproteinemia may lead to anasarca and peripheral oedema.</p>
<p>Very rarely jaundice may be seen in ascaris infection where there is biliary obstruction.</p>
<p>Stunted growth may be observed in children with severe infestations.</p>
<h2 id="investigations.">Investigations.</h2>
<p>It is not necessary to request investigations routinely. If they are considered they might include:</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>FBC (iron deficiency anaemia, eosinophilia)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Stool microscopy: The diagnosis is often confirmed with direct microscopic analysis of fecal samples to verify the presence of the worms or its ova.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Chest radiography: In cases of severe infection, chest x-ray may show diffuse alveolar infiltrates during the migration of the larvae through the lung. Once infection is established in the gut, imaging studies are not helpful.</p>
</div></li>
</ul>
<h2 id="management">Management</h2>
<p>Most common intestinal helminth infestations can be treated with either of the following:</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Oral albendazole</p>
</div>
<ul>
<li><div data-custom-style="List Paragraph">
<p>400 mg stat if 2 years or older</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>200 mg stat if between 1 and 2 years of age</p>
</div></li>
</ul></li>
<li><div data-custom-style="List Paragraph">
<p>Oral mebendazole 100 mg 12 hourly for 3 days.</p>
</div></li>
</ul>
<p>Avoid these medications if pregnant or planning to conceive in the next 1 month – Levamisole may sometimes be available and is safe for these patients. The dose is 2.5 mg/kg up to 150 mg stat.</p>
<p>Treatment course may be repeated after 3 weeks if infestation persists.</p>
<p>Preventive measures against helminthic infections include adequate sanitation, appropriate personal and food hygiene, and use of protective footwear.</p>
<p>Treatment peculiar to some intestinal helminthic infestations are shown below:</p>
<h3 id="enterobius-vermicularis">Enterobius vermicularis</h3>
<p>Treat patient and whole family with:</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Oral Mebendazole 100 mg od as single dose (repeat after 3 weeks if symptoms persist)</p>
</div></li>
</ul>
<p>or</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Oral Albendazole</p>
</div>
<ul>
<li><div data-custom-style="List Paragraph">
<p>2 years or older: 400 mg stat (repeat after 2 weeks)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>1-2 years: 200mg stat (repeat after 2 weeks)</p>
</div></li>
</ul></li>
</ul>
<h3 id="strongyloides-stercoralis">Strongyloides stercoralis</h3>
<p>The drug of choice is ivermectin 200 micrograms/kg as a single dose, or two doses on successive days. It is rarely available. It is not routinely recommended for children aged under 5 years and less than 15 kg, but has been used in younger children for mass drug administration with few adverse events.</p>
<p>The alternative is albendazole. WHO suggest for children ≤10kg: 200mg OD oral for 3 days, may repeat course in 3 weeks. For children or adolescents &gt;10kg: 400mg OD oral for 3 days, may repeat course in 3 weeks.</p>
<p>In hyperinfestation, ivermectin 200 micrograms/kg daily until stool microscopy is negative for 2 weeks.</p>
<p><strong><span class="underline">Tapeworms:</span></strong></p>
<p>Praziquantel 5-10 mg/kg as single dose (4 years and older).</p>
<h2 id="references">References</h2>
<p>Centers for Disease Control and Prevention. Strongyloides – Resources for Health Professionals. 2016. Available from: <a href="https://www.cdc.gov/parasites/strongyloides/health_professionals/index.html"><span data-custom-style="Hyperlink">www.cdc.gov/parasites/strongyloides/health_professionals/index.html</span></a> Accessed 15<sup>th</sup> August 2018</p>
<p>Hökelek M. Nematode Infections. Medscape. 2017. Available at <a href="https://emedicine.medscape.com/article/224011-overview"><span data-custom-style="Hyperlink">https://emedicine.medscape.com/article/224011-overview</span></a>. Accessed 15<sup>th</sup> August 2018</p>
<p>British National Formulary 70<sup>th</sup> edition. September 2015-March 2016.</p>
<p>Wilkins AL, Steer AC, Cranswick N, Gwee A. Question 1: Is it safe to use ivermectin in children less than five years of age and weighing less than 15 kg? <em>Archives of Disease in Childhood</em> 2018; <strong>103</strong>: 514–9.</p>
<table>
<thead>
<tr class="header">
<th><strong>Written by:</strong></th>
<th>Name: Amie Secka</th>
<th>Date: 16 July 2018</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Reviewed by:</strong></td>
<td>Name: Fatai Akemokwe</td>
<td>Date: 15 August 2018</td>
</tr>
<tr class="even">
<td><strong>Reviewed by</strong></td>
<td>Name Daisy Taylor</td>
<td>Date 30 June 2020</td>
</tr>
<tr class="odd">
<td><strong>Version:</strong></td>
<td><strong>Change history:</strong></td>
<td><strong>Review due date:</strong></td>
</tr>
<tr class="even">
<td>1.0</td>
<td>New document</td>
<td></td>
</tr>
<tr class="odd">
<td>2.0</td>
<td>Updated from previous version and made specific to intestinal helminths</td>
<td>20 August 2020</td>
</tr>
<tr class="even">
<td>2.1</td>
<td>Executive summary added</td>
<td>20 August 2020</td>
</tr>
<tr class="odd">
<td>3.0</td>
<td>Adjusted dosing of some medications according to WHO guidance</td>
<td>01 November 2022</td>
</tr>
<tr class="even">
<td>Review Comments (<em>if applicable)</em></td>
<td></td>
<td></td>
</tr>
</tbody>
</table>
</article>
</body>
</html>
